Forty-five million people – or 1 in 7 Americans – are living in poverty in the United States today. It often takes just one misfortune or one missed paycheck to change an individual or family’s life causing them to fall below the poverty line. Today, Catholic Charities USA (CCUSA) launches #End45 – Raise a Hand to End Poverty in America, a national initiative to help shine a spotlight on the issue and the millions of others in need or struggling to make ends meet.
Timed to coincide with Pope Francis’s visit to the United States in late September and to align with his commitment to helping the poor, #End45 – Raise a Hand to End Poverty in America encourages individuals to show support for the cause by taking a picture of their hand with “#End45” written on the palm and posting it to their social media channels using the hashtag #End45.
To view the multimedia release go to:
http://www.multivu.com/players/English/7599151-catholic-charities-end-poverty-in-america/
AbbVie (NYSE:ABBV) today marks its launch as an independent biopharmaceutical company, with employees from more than 40 countries and patients joining AbbVie leaders as they ring the first opening bell of 2013 at the New York Stock Exchange.
With a rich, 125-year heritage of developing pharmaceuticals, AbbVie combines the focus and passion of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. A global enterprise that serves patients in more than 170 countries, AbbVie launches with an estimated $18 billion in annual revenues and a strong commitment to creating shareholder value through long-term growth potential and the continuation of the company’s history of shareholder dividends.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59757-abbvie-celebrates-launch-as-new-biopharmaceutical-company
Federally funded research that provides a deep understanding of cancer is spurring advances against many types of the disease. With a strong bipartisan commitment from Congress to keep investment in biomedical research a national priority, we can accelerate our pace of progress and save more lives from cancer, according to the seventh annual American Association for Cancer Research (AACR) Cancer Progress Report, released today.
Basic research in the fields of immunology and cancer genetics has recently been harnessed to develop two new forms of cancer treatment: immunotherapy and precision medicine. As detailed in the report, the utility of these treatments is expanding rapidly. In May 2017, the U.S. Food and Drug Administration (FDA) heralded a new dawn for precision medicine when it approved the immunotherapeutic pembrolizumab (Keytruda) for treating patients with any solid tumor harboring specific genetic characteristics. This is the first anticancer therapeutic approved based on cancer biomarkers rather than the location in the body where the cancer originated.
To view the multimedia release go to:
https://www.multivu.com/players/English/8155051-aacr-cancer-progress-report-2017/
Women telling their stories and listening to other women’s stories: only by sharing their wisdom will the world’s women be able to build a better future for us all.
This is the philosophy behind “A Collection Of Us”, a brand new United Colors of Benetton collection, composed of four capsules which will be released in October, December, February and April, respectively. Heritage, technique, color, performance: each of the capsules revamps a central element of the brand’s identity by reinterpreting it and charging it with dynamic, contemporary meanings.
Knitwear, color and innovation hold “A Collection Of Us” together. The capsule collections bring this three-way alliance back to the center of the stage, highlighting the technical skills that create soft, polished, trendy, high performance knitwear, and drawing attention to the imaginativeness and forward looking spirit of Benetton fashion.
A global campaign will also be launched on October 22 to accompany “A Collection Of Us”. It will feature five female models, each belonging to a different generation and background, each carrying a message of emancipation and empowerment to be spread through digital and traditional media, and destined to all the world’s women.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7663951-new-commitment-for-all-the-worlds-women/
As part of an ongoing commitment to support life sciences innovators and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases, Johnson & Johnson today named cell biologist Yoshinori Ohsumi, Ph.D., of the Tokyo Institute of Technology the winner of the 2016 Dr. Paul Janssen Award for Biomedical Research for his pioneering discoveries concerning the molecular basis of autophagy.
Dr. Ohsumi was honored today during an event at the 2016 BIO International Convention in San Francisco. A video of his acceptance comments can be viewed here.
“Dr. Ohsumi’s curiosity led him to become the first person in the world to determine the molecular mechanism and regulation of autophagy, shedding light on one of the most basic functions of all living cells,” said Paul Stoffels, M.D., Chief Scientific Officer, Johnson & Johnson. “Dr. Ohsumi’s discoveries hold promise for better understanding, preventing and treating many diseases. It is with great pleasure that we celebrate his contributions, which remind us of the innovative spirit Dr. Paul brought to the lab every day.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7856351-2016-dr-paul-janssen-award-ohsumi/
Maytag® brand and Boys & Girls Clubs of America (BGCA) have awarded 11 Boys & Girls Clubs across America with the “2012 Maytag® Dependable Club Award” in recognition for their demonstrated commitment to dependability and dedication to keeping youth on the path to achieve great futures. The Clubs were selected to receive the distinction and a financial award to help deepen their impact in the community.
To view Multimedia News Release, go to http://www.multivu.com/mnr/59049-maytag-dependable-club-award-boys-girls-club-america-bgca-lucille-o-neal
Business consumers can now access video presentations from the fourth annual ERCOT Energy Seminar hosted by GDF SUEZ Energy Resources NA, one of the largest competitive retail electricity providers in the United States.
The event, which underscores the company’s commitment to being an information leader, called attention to a range of state, national, and global topics impacting the industry, including the Environmental Protection Agency’s Cross-State Air Pollution Rule (CSAPR).
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/gdfsuezenergyresources/50485/
